TP53 and neuroblastoma: We therefore suspect that the level of apoptosis we see is an underestimate of what these CBSIs could achieve in wild-type p53 cells, which is important to take into consideration due to the fact that neuroblastomas rarely contain TP53 mutations at the time of diagnosis [45].